A live webcast will be available on the Alumis website in the "Investors" section under the “Events” page. About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies ...

Christopher Nolan's next film will adapt Homer's epic poem 'The Odyssey,' and the cast is stacked for the feature film with a summer 2026 release date ...

Miles Teller (“Whiplash, “Top Gun: Maverick”) and Casey Affleck (“Manchester By the Sea,” “Oppenheimer”) are set to lead the cast of pursuit thriller “Wild Game.” “Wild Game” comes from ...

BILL (NYSE:BILL – Free Report) had its target price cut by Oppenheimer from $110.00 to $90.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have an ...

PROS (NYSE:PRO – Free Report) had its target price hoisted by KeyCorp from $28.00 to $31.00 in a research report released on Friday,Benzinga reports. They currently have an overweight rating on the ...

Oppenheimer reaffirmed its Outperform rating on Rockwell Automation (NYSE:ROK) with a steady price target of $300.00, positioning it within a range of analyst targets spanning from $215 to $355. The ...

Peter Oppenheimer, Goldman Sachs chief global equity strategist and head of macro research, joins 'Squawk Box' to discuss the latest market trends, why he believes that markets are vulnerable to a ...

In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...

Reports of a potential merger of Cboe Global Markets' (CBOE) and CME Group (CME) could revive on perceived lack of revenue ...

Although no Irish have been nominated in this year's Oscars, one Irish man will take to the stage and that is none other than ...

The company's press release indicated that the enrollment and dosing for the BEACON-IPF trial were voluntarily paused to review data and understand the DSMB's recommendation. While the study remains ...